79L-32064-28887
2 vaccinations
6 coded responses
21 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 605 / IL
- Registered
- 2021-08-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-30
Dose 1 — Pfizer-BioNTech
-
2021-08-31
Registered in v-safe
-
2021-08-31
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness — Feeling: Fair · Site: Pain, Itching · Be unable to do your normal daily activitiesFree text: DizzinessMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-01
Survey response — days 1–6 daily, dose 1MedDRA: Oropharyngeal pain — Feeling: FairFree text: Sore throatMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-02
Survey response — days 1–6 daily, dose 1MedDRA: Oropharyngeal pain — Feeling: FairFree text: Sore throatMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-09-04
- 2021-09-05
- 2021-09-06
- 2021-09-13
-
2021-09-22
Survey response — day 21, dose 1MedDRA: SARS-CoV-2 test negative, Upper respiratory tract infection — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Upper respiratory infection (tested covid negative)MedDRA releases: 2024-11 · check-in free text available
-
2021-09-25
Dose 2 — Pfizer-BioNTech
-
2021-09-25
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
-
2021-09-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body achesAdult check-in
-
2021-09-27
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2021-09-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Muscle or body achesAdult check-in
-
2021-09-29
Survey response — days 1–6 daily, dose 2MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good · Site: PainFree text: Ankle swelling has been noticeably worse since last weekend (when vaccine was administered). Still mild-moderate but a definite changeMedDRA releases: 2024-11 · check-in free text available
- 2021-10-01
- 2021-10-02
-
2021-10-09
Survey response — day 14, dose 2MedDRA: Nasal congestion, Rhinorrhoea, Upper respiratory tract infection — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Upper respiratory infection, nasal congestion/rhinorrheaMedDRA releases: 2024-11 · check-in free text available
- 2021-10-23
- 2021-10-31
- 2021-11-06
- 2021-12-28
- 2022-03-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-30 | Pfizer-BioNTech | No |
| 2 | 2021-09-25 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Dizziness
Systemic reaction (other): Sore throat
Systemic reaction (other): Sore throat
Release 9 — day 21, dose 1
Symptoms: Upper respiratory infection (tested covid negative)
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Ankle swelling has been noticeably worse since last weekend (when vaccine was administered). Still mild-moderate but a definite change
Release 10 — day 14, dose 2
Symptoms: Upper respiratory infection, nasal congestion/rhinorrhea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasal congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Condition aggravated | · | · | ✓ |
| SRO | Dizziness | ✓ | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release